DAYAN, S.; OGILVIE, P.; RIVKIN, A. Z.; YOELIN, S. G.; GARCIA, J. K.; FERRUSI, I. L. OnabotulinumtoxinA for Treatment of Moderate-to-Severe Horizontal Lines and Glabellar Lines from the Subject’s Perspective: Patient-Reported Satisfaction and Impact Outcomes from a Phase 3 Double-Blind Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 1, n. 3.1, p. s82, 2017. DOI: 10.25251/skin.1.supp.81. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/86. Acesso em: 23 jul. 2024.